CRASH! Why the BT Investment Management Ltd share price cratered today

BT Investment Management Ltd (ASX:BTT) shares have sunk like a stone today. Here's why they're down…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It hasn't been a great start to the day for BT Investment Management Ltd (ASX: BTT) shareholders. In morning trade BTIM's share price fell as much as 8.9% to $10.10 despite there being no news out of the fund manager.

Today's decline is likely to be the result of a research note out of investment bank Credit Suisse which revealed that its analysts have downgraded BTIM to an underperform rating.

According to the note Credit Suisse's analysts are concerned that the company's UK-based JO Hambro business will disappoint when BTIM releases its next quarterly update in mid-January.

They estimate that accrued performance fees at the end of November were approximately half the level they were at the end of the September quarter.

If this proves to be the case then I'm not surprised to see the share price plunge. The JO Hambro business is the company's key business, providing 77% of BTIM's cash profit in FY 2016. If it misfires then BTIM's performance as a whole will be dragged down with it.

Whilst at this stage these are just estimates from Credit Suisse, there have been numerous reports recently about how the United Kingdom is losing out on billions of pounds worth of investment post-Brexit. So it isn't hard to imagine the JO Hambro business suffering as a result.

Regardless of these concerns I felt BTIM was a little on the expensive side already. Today's drop has brought its shares down to a more reasonable level, but I would still hold off an investment at least until it releases its quarterly update in January.

Until then investors might be better served with an investment in either WAM Capital Limited (ASX: WAM) or FORAGER AU FPO (ASX: FOR) instead.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »